Correlation Between Visa and OWC Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and OWC Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and OWC Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and OWC Pharmaceutical Research, you can compare the effects of market volatilities on Visa and OWC Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of OWC Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and OWC Pharmaceutical.

Diversification Opportunities for Visa and OWC Pharmaceutical

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Visa and OWC is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and OWC Pharmaceutical Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OWC Pharmaceutical and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with OWC Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OWC Pharmaceutical has no effect on the direction of Visa i.e., Visa and OWC Pharmaceutical go up and down completely randomly.

Pair Corralation between Visa and OWC Pharmaceutical

Taking into account the 90-day investment horizon Visa is expected to generate 1731.76 times less return on investment than OWC Pharmaceutical. But when comparing it to its historical volatility, Visa Class A is 379.73 times less risky than OWC Pharmaceutical. It trades about 0.09 of its potential returns per unit of risk. OWC Pharmaceutical Research is currently generating about 0.4 of returns per unit of risk over similar time horizon. If you would invest  0.01  in OWC Pharmaceutical Research on August 30, 2024 and sell it today you would earn a total of  0.00  from holding OWC Pharmaceutical Research or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Visa Class A  vs.  OWC Pharmaceutical Research

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
OWC Pharmaceutical 

Risk-Adjusted Performance

26 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in OWC Pharmaceutical Research are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile fundamental indicators, OWC Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Visa and OWC Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and OWC Pharmaceutical

The main advantage of trading using opposite Visa and OWC Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, OWC Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OWC Pharmaceutical will offset losses from the drop in OWC Pharmaceutical's long position.
The idea behind Visa Class A and OWC Pharmaceutical Research pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.